Caveolin-1 Expression Level in Cancer Associated Fibroblasts Predicts Outcome in Gastric Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhao, Xianda ^a   He, Yuyu ^a   Gao, Jun ^b   Fan, Lifang ^a   Li, Zonghuan ^a   Yang, Guifang ^c   Chen, Honglei ^a,d  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Nano Tumor Diagnosis Engineering Research Center   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CAVEOLIN 1; QUANTUM DOT;

ABSORPTIVE CELL; ADULT; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; FIBROBLAST; FUNDIC GLAND CELL; GASTRITIS; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURVIVAL RATE; TUMOR CELL;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; CAVEOLIN 1; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN BINDING; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84875115414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059102     Document Type: Article

References (38)

1. Dvorak HF, Weaver VM, Tlsty TD, Bergers G, (2011) Tumor microenvironment and progression. J Surg Oncol 103: 468-474.
2. Mueller MM, Fusenig NE, (2004) Friends or foes- bipolar effects of the tumour stroma in cancer. Nature reviews Cancer 4: 839-849.
3. Bissell MJ, Radisky D, (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54.
4. Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, et al. (2011) Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 102: 1590-1596.
5. Simpkins SA, Hanby AM, Holliday DL, Speirs V, (2012) Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J Pathol 227: 490-498.
6. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, et al. (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174: 2023-2034.
7. Paulsson J, Sjoblom T, Micke P, Ponten F, Landberg G, et al. (2009) Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol 175: 334-341.
8. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, et al. (2009) An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8: 2420-2424.
9. Li M, Li C, Li D, Xie Y, Shi J, et al. (2012) Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clinical & Experimental Metastasis 29: 865-877.
10. Adegboyega PA, Rodriguez S, McLarty J, (2010) Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma. Human Pathology 41: 1128-1137.
11. Engelman JA, Zhang XL, Galbiati F, Lisanti MP, (1998) Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1,-2, and-3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 429: 330-336.
12. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, et al. (2012) Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 7: 423-467.
13. Anderson RG, (1998) The caveolae membrane system. Annu Rev Biochem 67: 199-225.
14. Goetz JG, Lajoie P, Wiseman SM, Nabi IR, (2008) Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 27: 715-735.
15. Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, et al. (2009) Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 174: 2035-2043.
16. Xue J, Chen H, Diao L, Chen X, Xia D, (2010) Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots. Eur J Histochem 54: 99-103.
17. Alivisatos AP, (1996) Semiconductor Clusters, Nanocrystals, and Quantum Dots. Science 271: 933-937.
18. Li ZH, Peng J, Chen HL, (2011) Bioconjugated quantum dots as fluorescent probes for biomedical imaging. J Nanosci Nanotechnol 11: 7521-7536.
19. Chen C, Peng J, Xia HS, Yang GF, Wu QS, et al. (2009) Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials 30: 2912-2918.
20. Chen C, Sun SR, Gong YP, Qi CB, Peng CW, et al. (2011) Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2. Biomaterials 32: 7592-7599.
21. Liu XL, Peng CW, Chen C, Yang XQ, Hu MB, et al. (2011) Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem Biophys Res Commun 409: 577-582.
22. Chen H, Xue J, Zhang Y, Zhu X, Gao J, et al. (2009) Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol 40: 261-268.
23. Chen C, Peng J, Xia H, Wu Q, Zeng L, et al. (2010) Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity. Nanotechnology 21: 095101.
24. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
25. Li M, Chen H, Diao L, Zhang Y, Xia C, et al. (2010) Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori 96: 734-743.
26. Sun Gy, Wu Jx, Wu Js, Pan Yt, Jin R, (2012) Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis. Chinese J Cancer Res 24: 23-28.
27. Barresi V, Giuffre G, Vitarelli E, Todaro P, Tuccari G, (2008) Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. Virchows Arch 453: 571-578.
28. Burgermeister E, Xing X, Rocken C, Juhasz M, Chen J, et al. (2007) Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67: 8519-8526.
29. Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffre G, et al. (2006) Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol 112: 617-626.
30. Williams TM, Lisanti MP, (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288: C494-506.
31. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, et al. (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933.
32. Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T, (2006) Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Int J Mol Med 17: 3-13.
33. Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, et al. (2009) Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 125: 1832-1841.
34. Zhang H, Su L, Muller S, Tighiouart M, Xu Z, et al. (2008) Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 99: 1684-1694.
35. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
36. Goetz JG, Minguet S, Navarro-Lerida I, Lazcano JJ, Samaniego R, et al. (2011) Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146: 148-163.
37. Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, et al. (2009) Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle 8: 1654-1658.
38. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.